Aimei Health Ownership
AFJKU Stock | 10.95 0.00 0.00% |
Aimei |
Aimei Stock Ownership Analysis
About 18.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. For more info on Aimei Health Technology please contact Junheng Xie at 212 845 9945.Besides selling stocks to institutional investors, Aimei Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Aimei Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Aimei Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Aimei Health Quarterly Liabilities And Stockholders Equity |
|
About 6.0% of Aimei Health Technology are currently held by insiders. Unlike Aimei Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Aimei Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Aimei Health's insider trades
Aimei Health Technology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aimei Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aimei Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aimei Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aimei Investment Ltd over a year ago Purchase by Aimei Investment Ltd of 332000 shares of Aimei Health | ||
Aimei Investment Ltd over a year ago Aimei Health exotic insider transaction detected |
Aimei Health Corporate Filings
8K | 14th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10th of January 2025 Other Reports | ViewVerify | |
3rd of December 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aimei Stock Analysis
When running Aimei Health's price analysis, check to measure Aimei Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aimei Health is operating at the current time. Most of Aimei Health's value examination focuses on studying past and present price action to predict the probability of Aimei Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aimei Health's price. Additionally, you may evaluate how the addition of Aimei Health to your portfolios can decrease your overall portfolio volatility.